Themiset 0.25mg Injection
By Themiset
Rx
5ml Injection in a Vial

Composition
Palonosetron(0.25mg)

Manufacturer - Themis Medicare Ltd
11/12, Udyog Nagar, S. V. Road, Goregaon (W), Mumbai- 400104.

Expires on or after
August, 2025

liver
Themiset 0.25mg Injection is considered safe for use in individuals with liver disease. It is important to note that no dose adjustment of Themiset 0.25mg Injection is necessary in patients with liver issues. It appears that the medication does not pose a significant risk to individuals with liver conditions. Please follow the recommended dosage and consult with your healthcare provider for more personalized advice.

kidney
Themiset 0.25mg Injection is considered safe for individuals with kidney disease. There is no need for dose adjustment when using this medication.

alcohol
Consult your doctor when consuming alcohol with Themiset 0.25mg Injection.

driving
When using Themiset 0.25mg Injection, be careful as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if you experience these side effects.

pregnancy
Themiset 0.25mg Injection is generally considered safe for use during pregnancy. Animal studies indicate minimal adverse effects on the developing baby, but human studies are limited.

breastfeeding
Themiset 0.25mg Injection is likely safe during breastfeeding. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | Isoquinoline and Quinuclidine Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Serotonin antagonists (5-HT3 antagonists) |
₹132
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024